The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•11 February 2026•

1 min read

Wealthfront Boosts Amgen Stake Amid Strong Earnings and Dividend Hike

A man in a suit over a stock chart with 'Mondelez International' text, surrounded by chocolate, cocoa beans, factories, and shops.

Wealthfront Advisers LLC significantly increased its position in Amgen Inc. during the third quarter, raising its stake by 22.4%. The investment firm now holds 70,233 shares of Amgen, valued at an estimated $19.82 million. This move comes as Amgen reported robust fourth-quarter earnings, surpassing analyst expectations. Furthermore, the biotechnology giant demonstrated its commitment to shareholder returns by increasing its quarterly dividend to $2.52 per share. Despite a recent 3.0% dip in Amgen's stock price, Wealthfront's expanded holding suggests confidence in the company's underlying financial strength and future prospects. This strategic increase by a prominent advisory firm highlights Amgen's appeal to institutional investors.